These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2905658)

  • 1. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of alpha 2-adrenoceptors by 1-(2-pyrimidinyl)-piperazine (PmP) in vivo and its relation to the activity of buspirone.
    Bianchi G; Garattini S
    Eur J Pharmacol; 1988 Mar; 147(3):343-50. PubMed ID: 2897918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
    Blier P; Curet O; Chaput Y; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems.
    Giral P; Soubrie P; Puech AJ
    Eur J Pharmacol; 1987 Jan; 134(1):113-6. PubMed ID: 2881793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1990 Jan; 4(4):204-9. PubMed ID: 22281849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.
    Caccia S; Conti I; Viganò G; Garattini S
    Pharmacology; 1986; 33(1):46-51. PubMed ID: 2874572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of buspirone, gepirone, ipsapirone and their common metabolite 1-(2-pyrimidinyl)piperazine in rat plasma and brain by high-performance liquid chromatography.
    Bianchi G; Caccia S
    J Chromatogr; 1988 Oct; 431(2):477-80. PubMed ID: 2907515
    [No Abstract]   [Full Text] [Related]  

  • 14. Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity.
    Sanghera MK; Coke JA; Williams HL; McMillen BA
    Brain Res Bull; 1990 Jan; 24(1):17-22. PubMed ID: 2310943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat.
    Cullen WK; Rowan MJ
    Pharmacol Biochem Behav; 1994 May; 48(1):301-6. PubMed ID: 7913229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of clonidine antinociception by buspirone and 1-(2-pyrimidinyl)-piperazine.
    Cao BJ; Li WP
    Eur J Pharmacol; 1994 Jun; 259(1):75-8. PubMed ID: 7957598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
    McMillen BA; Scott SM; Williams HL; Sanghera MK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S; Fong MH; Guiso G
    Xenobiotica; 1985 Oct; 15(10):835-44. PubMed ID: 2866634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma.
    Matheson GK; Gage-White D; White G; Guthrie D; Rhoades J; Dixon V
    Neuropharmacology; 1989 Apr; 28(4):329-34. PubMed ID: 2747846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
    Kehne JH; Cassella JV; Davis M
    Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.